Erratum to "Akt2 knockout mitigates chronic iNOS inhibition-induced cardiomyocyte atrophy and contractile dysfunction despite persistent insulin resistance" [Toxicol. Lett. 207 (3) (2011) 222-231] DOI: 10.1016/j.toxlet.2011.09.015;Akt2 knockout mitigates chronic iNOS inhibition-induced cardiomyocyte atrophy and contractile dysfunction despite persistent insulin resistance

Toxicology Letters

Volumn 207, Issue 3, 2011, Pages 222-231

  Roe, Nathan D ^a   Ren, Jun ^a  

^a UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

Author keywords

Akt; Myocardial contractile function; Nitric oxide

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; PHOSPHOLAMBAN; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN KINASE B BETA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ARTICLE; ATROPHY; AUTOPHAGY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME INHIBITION; GENE SILENCING; GLUCOSE TOLERANCE; HEART CONTRACTION; HEART MUSCLE CELL; HEART WEIGHT; INSULIN RESISTANCE; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

MUS;

EID: 80053916348     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2016.02.006     Document Type: Erratum

References (32)

1. Bai-Feng L., Yong-Feng L., Ying C. Silencing inducible nitric oxide synthase protects rat pancreatic islet. Diabetes Res. Clin. Pract. 2010, 89:268-275.
2. Carvalho-Filho M.A., Ueno M., Hirabara S.M., Seabra A.B., Carvalheira J.B., de Oliveira M.G., Velloso L.A., Curi R., Saad M.J. S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes 2005, 54:959-967.
3. Ceriello A., Quagliaro L., D'Amico M., Di Filippo C., Marfella R., Nappo F., Berrino L., Rossi F., Giugliano D. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 2002, 51:1076-1082.
4. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw E.B., Kaestner K.H., Bartolomei M.S., Shulman G.I., Birnbaum M.J. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001, 292:1728-1731.
5. De Meyer G.R., De Keulenaer G.W., Martinet W. Role of autophagy in heart failure associated with aging. Heart Fail. Rev. 2010, 15:423-430.
6. Dong F., Yang X., Sreejayan N., Ren J. Chromium (d-phenylalanine)3 improves obesity-induced cardiac contractile defect in ob/ob mice. Obesity (Silver Spring) 2007, 15:2699-2711.
7. Dong F., Zhang X., Yang X., Esberg L.B., Yang H., Zhang Z., Culver B., Ren J. Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice. J. Endocrinol. 2006, 188:25-36.
8. Doser T.A., Turdi S., Thomas D.P., Epstein P.N., Li S.Y., Ren J. Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction. Circulation 2009, 119:1941-1949.
9. Etzion S., Etzion Y., DeBosch B., Crawford P.A., Muslin A.J. Akt2 deficiency promotes cardiac induction of Rab4a and myocardial beta-adrenergic hypersensitivity. J. Mol. Cell. Cardiol. 2010, 49:931-940.
10. Fang C.X., Dong F., Ren B.H., Epstein P.N., Ren J. Metallothionein alleviates cardiac contractile dysfunction induced by insulin resistance: role of Akt phosphorylation, PTB1B, PPARgamma and c-Jun. Diabetologia 2005, 48:2412-2421.
11. Garvey E.P., Oplinger J.A., Furfine E.S., Kiff R.J., Laszlo F., Whittle B.J., Knowles R.G. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 1997, 272:4959-4963.
12. Hers I., Vincent E.E., Tavare J.M. Akt signalling in health and disease. Cell. Signal. 2011, 23:1515-1527.
13. Kandadi M.R., Unnikrishnan M.K., Warrier A.K., Du M., Ren J., Sreejayan N. Chromium (d-phenylalanine)3 alleviates high fat-induced insulin resistance and lipid abnormalities. J. Inorg. Biochem. 2011, 105:58-62.
14. Leng S., Zhang W., Zheng Y., Liberman Z., Rhodes C.J., Eldar-Finkelman H., Sun X.J. Glycogen synthase kinase 3 beta mediates high glucose-induced ubiquitination and proteasome degradation of insulin receptor substrate 1. J. Endocrinol. 2010, 206:171-181.
15. Lu M., Li P., Pferdekamper J., Fan W., Saberi M., Schenk S., Olefsky J.M. Inducible nitric oxide synthase deficiency in myeloid cells does not prevent diet-induced insulin resistance. Mol. Endocrinol. 2010, 24:1413-1422.
16. Manning W.J., Wei J.Y., Katz S.E., Litwin S.E., Douglas P.S. In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. Am. J. Physiol. 1994, 266:H1672-H1675.
17. Nagareddy P.R., McNeill J.H., MacLeod K.M. Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats. Eur. J. Pharmacol. 2009, 611:53-59.
18. Nagareddy P.R., Xia Z., McNeill J.H., MacLeod K.M. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am. J. Physiol. 2005, 289:H2144-H2152.
19. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
20. Pasini E., Aquilani R., Gheorghiade M., Dioguardi F.S. Malnutrition, muscle wasting and cachexia in chronic heart failure: the nutritional approach. Ital. Heart J. 2003, 4:232-235.
21. Penumathsa S.V., Thirunavukkarasu M., Zhan L., Maulik G., Menon V.P., Bagchi D., Maulik N. Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J. Cell. Mol. Med. 2008, 12:2350-2361.
22. Perreault M., Marette A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat. Med. 2001, 7:1138-1143.
23. Pitocco D., Zaccardi F., Di Stasio E., Romitelli F., Santini S.A., Zuppi C., Ghirlanda G. Oxidative stress, nitric oxide, and diabetes. Rev. Diabet. Stud. 2010, 7:15-25.
24. Rajesh M., Mukhopadhyay P., Batkai S., Patel V., Saito K., Matsumoto S., Kashiwaya Y., Horvath B., Mukhopadhyay B., Becker L., Hasko G., Liaudet L., Wink D.A., Veves A., Mechoulam R., Pacher P. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J. Am. Coll. Cardiol. 2010, 56:2115-2125.
25. Ren J., Pulakat L., Whaley-Connell A., Sowers J.R. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J. Mol. Med. (Berl.) 2010, 88:993-1001.
26. Soliman H., Craig G.P., Nagareddy P., Yuen V.G., Lin G., Kumar U., McNeill J.H., Macleod K.M. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats. Cardiovasc. Res. 2008, 79:322-330.
27. Song D., Kuo K.H., Yao R., Hutchings S.R., Pang C.C. Inducible nitric oxide synthase depresses cardiac contractile function in Zucker diabetic fatty rats. Eur. J. Pharmacol. 2008, 579:253-259.
28. Sulakhe P.V., Vo X.T. Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization. Mol. Cell. Biochem. 1995, 149-150:103-126.
29. Turdi S., Kandadi M.R., Zhao J., Huff A.F., Du M., Ren J. Deficiency in AMP-activated protein kinase exaggerates high fat diet-induced cardiac hypertrophy and contractile dysfunction. J. Mol. Cell. Cardiol. 2011, 50:712-722.
30. Wang D., Patel V.V., Ricciotti E., Zhou R., Levin M.D., Gao E., Yu Z., Ferrari V.A., Lu M.M., Xu J., Zhang H., Hui Y., Cheng Y., Petrenko N., Yu Y., FitzGerald G.A. Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:7548-7552.
31. Xie Z., Lau K., Eby B., Lozano P., He C., Pennington B., Li H., Rathi S., Dong Y., Tian R., Kem D., Zou M.H. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes 2011, 60:1770-1778.
32. Ziolo M.T., Kohr M.J., Wang H. Nitric oxide signaling and the regulation of myocardial function. J. Mol. Cell. Cardiol. 2008, 45:625-632.